← Eichor
Study identifier: NCT05398185 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

WiseApp for Spanish Speakers Living With HIV

Condition: HIV Infections · Acquired Immune Deficiency Syndrome · Sexually Transmitted Diseases, Viral  ·  Sponsor: Columbia University

PhaseNA
Planned participants248
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to conduct a 12-month randomized controlled trial to adapt the mobile app, WiseApp, and a smart pill dispenser for Spanish-speaking people living with HIV (PLWH) in the New York City (NYC) area and La Romana, Dominican Republic (DR). The study will assess the efficacy and sustainability of WiseApp as well as identify barriers with its widespread use among Spanish speakers. With disproportionately high rates of HIV in the New York City area and the Dominican Republic, this project seeks to identify distinct contextual factors related to Spanish speaking people living with HIV and increase the likelihood of engagement with technology and improvements in clinical outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Rebecca Schnall, PhD, MPH  ·  212-342-6886  ·  rb897@columbia.edu

Claudia Michaels  ·  clm2241@cumc.columbia.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Columbia University Irving Medical CenterNew York, New York, United StatesRecruiting
Clinica de Familia La RomanaLa Romana, Dominican RepublicRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05398185